Having trouble accessing articles? Reset your cache.

Diazepam nasal spray: Phase I data

An open-label, crossover Phase I trial in 24 healthy volunteers showed that a single 20 mg dose of diazepam nasal

Read the full 200 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE